Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Contracts
  • Global
  • News

Omniq’s AI Based Machine Vision Solution Purchased For The El Salvador International Airport; No Financial Terms Disclosed

By Benzinga Newsdesk
September 20, 8:45 AM
First international Airport to use OMNIQ's AI in Central America. A new potential market for OMNIQ.

OMQS

Read More
2 minute read
  • News
  • Tech

‘Never Thought I Would Ever Need That Feature’: Apple Watch Saves Life In A Highway Car Crash

By Rounak Jain
September 20, 8:42 AM
The user was left unconscious after the crash, but their Apple Watch called 911 and sent an SOS message to their parents.

AAPL

Read More
2 minute read
  • Long Ideas
  • Markets
  • Media
  • News
  • Small Cap
  • Trading Ideas

Cramer Warns Investors About This AI Company Up 146% YTD: ‘Too Much Hype, Too Much Fluff’

By Priya Nigam
September 20, 8:39 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Micron Technology, Inc. (NASDAQ: MU) is "coming out of the trough, I agree with the hype.

AI

Read More
2 minute read
  • General
  • News
  • Politics

RealClearPolitics And Stagwell Partner To Power Advanced Site And Advertising Platform For The 2024 U.S. Presidential Election Cycle

By Benzinga Newsdesk
September 20, 8:37 AM
Stagwell (NASDAQ:STGW), the challenger network built to transform marketing, today announced it will partner with RealClearPolitics (RCP), an independent, non-partisan media company, to create an enhanced polling

STGW

Read More
2 minute read
  • Events
  • News

Zoom X Running On Vuzix Smart Glasses Highlights 5G Solutions At Deutsche Telekom’s Digital X 2023 Exhibition

By Benzinga Newsdesk
September 20, 8:35 AM
Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced that the Company will be broadly showcasing

VUZI

Read More
2 minute read
  • News

CyberArk Collaborates With Accenture To Deliver Advanced Privileged Access Management Solutions For Clients

By Benzinga Newsdesk
September 20, 8:34 AM
CyberArk (NASDAQ:CYBR), the identity security company, today announced that Accenture, a leading global professional services company, has expanded its deployment of the CyberArk Identity Security Platform to include

ACN

Read More
1 minute read
  • Equities
  • General
  • Markets
  • News

Moody’s Ignites Vietnam’s Financial Scene With Pioneering VIS Credit Rating Venture

By Nabaparna Bhattacharya
September 20, 8:33 AM
Moody's Corporation (NYSE: MCO) unveiled the 

MCO

Read More
2 minute read
  • Biotech
  • General
  • News

LIXTE Biotechnology Announces A Supported Collaborative Trial To Study LIXTE’s First-In-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, In Clear-Cell Ovarian Cancer

By Benzinga Newsdesk
September 20, 8:31 AM
The Phase 1b Clinical Trial Focuses on Assessing the Safety and Efficacy of the Two-Drug Combination in a Cancer Associated with Longer Survival to Immunotherapy When Genetically Deficient in PP2A PASADENA, CA,

LIXT

Read More
4 minute read
  • Biotech
  • General
  • News

Relmada Therapeutics Announces Efficacy And Safety Results From The Phase 3 Long-Term Study Of REL-1017 In Major Depressive Disorder

By Benzinga Newsdesk
September 20, 8:31 AM
Patients newly treated with REL-1017 for up to one year experienced rapid, clinically meaningful, and sustained improvements in depressive symptoms and associated functional impairmentLong-term dosing with REL-1017 was

RLMD

Read More
2 minute read
  • Insider Trades
  • Markets
  • News
  • Pre-Market Outlook
  • Short Ideas
  • Trading Ideas

Seagate, Lyft And 2 Other Stocks Insiders Are Selling

By Lisa Levin
September 20, 8:29 AM
The Nasdaq 100 closed lower on Tuesday. Investors, meanwhile, focused on some notable insider trades.

J

Posts pagination

Previous 1 … 6,722 6,723 6,724 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service